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Abstract
Background The outcome of organs which have been declined for paediatric recipients is not known. This study aimed to
determine the outcome of kidneys initially declined for paediatric recipients and establish renal allograft survival in kidneys that
were eventually transplanted.
Methods Data were obtained from the UK Transplant Registry for all donation after brain death (DBD) kidneys offered and
declined to paediatric recipients (< 18 years) in the UK from 2009 to 2014.
Results Eighty-two percent (503/615) of kidneys initially declined for paediatric transplantation were eventually transplanted,
7% (46/615) of kidneys went to paediatric recipients and 62% (384/615) of kidneys went to adult (kidney only) recipients. The
remainder were used for multiple organ transplants. In the 46 kidneys that went to paediatric recipients, 1 and 3-year renal
allograft survivals were 89% (95% CI 75.8–95.3%) and 82% (95% CI 67.1–90.6%), respectively. In the 384 kidneys given to
adult kidney-only recipients, 1 and 3-year renal allograft survivals were 96% (95% CI 93.5–97.6%) and 94% (95% CI 90.7–
96.1%), respectively. Eighty-four percent of the 204 children who initially had an offer declined on their behalf were eventually
transplanted and have a functioning graft at a median 3-year follow-up.
Conclusions This study reports acceptable short-term renal allograft survival in kidneys that were initially declined for paediatric
recipients and subsequently transplanted. Evidence-based guidelines are required to ensure that the most appropriate kidneys are
selected for paediatric recipients.
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Introduction
Pre-emptive renal transplantation is the gold standard renal
replacement therapy for children with end-stage kidney dis-
ease (ESKD). There is a significant body of adult data
supporting the advantages of renal transplantation over dialy-
sis, including improved survival and quality of life [1–3]. The
deleterious effects of long-term sub-optimal dialysis in chil-
dren are even more pronounced, including additional negative
effects on growth and development. The priority for many
paediatric nephrologists is to perform pre-emptive, in most
cases live-related, renal transplantation for children, but where
a living donor is not available, a child may be listed for a
donation after brain death (DBD) and/or donation after cardiac
death (DCD) kidney transplant. In the UK, paediatric patients
receive the highest priority for deceased donor kidney offers
(at each HLA match level), as well as receiving additional
priority points if their HLA match is not favourable.
Transplant networks in different countries vary in their or-
gan procurement and allocation methods, but when a DBD
kidney is matched to a paediatric recipient, the child’s ne-
phrologist and transplant surgeon make the decision whether
to accept this kidney for this child. This decision is a time-
critical one which needs to be made quickly [4]. Paediatric
transplant centres in the UK have 45 min to respond to a
DBD kidney offer. This is a challenging decision where the
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potential benefits of transplantation need to outweigh the
risks. The risks in transplantation include a variety of donor
and recipient factors [5–7], and sometimes an offer of a kidney
is declined for a paediatric recipient.Whilst there are a number
of possible reasons for decline, the most frequent reasons for
decline are not well described in the literature.
Kidneys which are declined for donor factors, such as poor
donor health or cause of death, may not be suitable for trans-
plantation in any recipient. Other kidneys which are declined
may subsequently be offered to another recipient (adult or
child) and may be successfully transplanted. There are no
reports in the literature which systematically evaluate the out-
come in kidneys which have been declined for paediatric
transplantation.
The outcome for children who have a kidney transplant
declined on their behalf is also poorly understood, and further
evidence is required to help clinicians decide whether a child
may benefit from accepting a kidney sooner rather than
waiting for a kidney of potentially higher quality or
appropriateness.
The primary aim of this study was to determine the out-
come of kidneys which were declined for paediatric recipients
and establish renal allograft survival in those kidneys that
were eventually transplanted. Secondary aims were to inves-
tigate the outcomes for children who had a kidney declined on
their behalf and to investigate the most common reasons for
declining a kidney for a paediatric recipient.
Materials and methods
This study was conducted into two parts, a retrospective anal-
ysis of national data from the UK Transplant Registry and a
prospective observational study.
Retrospective analysis of kidney and patient
outcomes after a declined kidney transplant offer
for a paediatric recipient
Data were obtained from the UK Transplant Registry for all
DBD kidneys offered and declined for paediatric recipients
under 18 years of age in the UK from 1 January 2009 to 31
December 2014. Data on the total number of paediatric trans-
plants and the number of children on the transplant waiting list
at 1 January of each year was also collected.
Outcome of kidneys that were initially declined
for paediatric transplantation
We performed a retrospective analysis on the final outcome of
kidneys declined on behalf of paediatric recipients during this
time period, categorising kidneys as not transplanted or
transplanted, and separating the latter category into the type
of transplant. One and 3-year patient and renal allograft sur-
vival were calculated where the kidney was eventually
transplanted. Data were separately analysed for those kidneys
declined for donor reasons or inappropriate size for paediatric
recipients.
Outcome in paediatric patients for whom a kidney
was offered and declined
The outcomes for the patients for whom the kidney was of-
fered and declined were examined. Children were categorised
into those who received a transplant and those who were still
waiting for a transplant, and then sub-divided according to
this. For those children who received a kidney transplant after
their declined offer, the time from first declined offer to trans-
plantation was calculated. Those children who had an initial
decline for donor health or size mismatch were analysed sep-
arately, in order to eliminate those where the kidney decline
was purely due to recipient reasons (e.g. recipient acutely
unwell at the time of kidney offer). This was felt to give the
clearest data representing organs that were declined for donor
reasons and could be transplanted into other recipients.
Prospective study of reasons for decline of a kidney
for a paediatric recipient
For two separate years (2011 and 2014), a prospective obser-
vational study was conducted. During these years (from 1
January to 31 December in each year), the paediatric renal
transplant centre that had declined an organ for a paediatric
recipient received a supplemental data collection form to com-
plete which requested additional information on the reason for
declining the kidney for the paediatric recipient, with both
generic reasons for decline and the option of free text com-
ments as required (examples of generic reasons included; do-
nor unsuitable due to cause of death, meningococcemia with
< 48 h of treatment, no staff/theatre time, etc.). In addition to
the routine data held by the UK Transplant Registry on de-
clined offers, donor and recipient characteristics and anthro-
pometrics were analysed.
Statistical analysis
Results were analysed using summary statistics and 95% con-
fidence intervals calculated as appropriate. The Kaplan-Meier
method was used to estimate univariate post-transplant patient
and renal allograft survival separately for all cases where the
kidney was subsequently transplanted after being declined for
a paediatric patient. Death censored renal allograft survival
was defined as time from renal transplantation to renal allo-
graft failure. Patient survival was defined as time from trans-
plant to patient death censoring for patients still alive at the
time of analysis.
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Data were fully anonymised and ethical principles adhered
to throughout the study; external ethical review was not re-
quired. Statistical analyses were performed in SAS version 9.2
(SAS Institute Inc., Cary, North Carolina, USA). All statistical
tests are two-tailed and a p value of < 0.05 was considered
statistically significant.
Results
Retrospective analysis of kidney and patient
outcomes after a declined kidney transplant offer
for a paediatric recipient
The total number of declined paediatric kidney offers per year
reduced during the study as did the total number of children on
the active kidney transplant waiting list (Fig. 1).
Outcome of kidneys that were initially declined
for paediatric transplantation
Four hundred and two DBD kidney offers from 308 different
donors were declined for 204 different paediatric recipients
from 2009 to 2014 in the UK. Some donor kidneys were of-
fered to multiple children on the waiting list as some were
declined more than once. Two hundred and four children had
kidneys declined on their behalf, and some children had mul-
tiple kidney declines. Six hundred and fifteen kidneys were
available for transplantation from the 308 donors who were
declined for paediatric transplantation. We analysed the out-
come for both kidneys (where the donor had two kidneys) even
if only one of the kidneys was declined for paediatric trans-
plantation. Therefore, the analysis of outcomes for 615 kidneys
exceeds the number of declined offers (402); see Fig. 2.
Of 615 kidneys from 308 donors declined for paediatric
recipients during the 6 years of the study, 7% (46) of 615
kidneys went to paediatric recipients (kidney-only), 74%
(457) of 615 kidneys went to adult recipients (62% kidney-
only and 10% simultaneous pancreas and kidney (Table 1).
The remaining 2%were either double kidney or another multi-
organ transplant involving a kidney; the numbers in this group
were too small to perform separate survival analysis).
Fig. 1 Total number of kidney
offers declined for paediatric
recipients from 2009 to 2014,
with the total number of
transplants in children and
number of children on the active
kidney transplant waiting list (all
values are per calendar year
across the UK). Type of kidney
transplants: DBD donation after
brain death, DCD donation after
cardiac death, LD living donor
Fig. 2 Flow diagram showing the number of recipients, donors and
kidneys involved in each stage of this study, considering kidney offers
declined for paediatric recipients in the UK from 2009 to 2014. The
outcomes of kidneys initially declined for paediatric recipients are also
shown
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Eighteen percent (112) of 615 kidneys were not transplanted
(Fig. 2).
Of 485 kidneys from 243 donors declined due to donor
reasons or size mismatch for paediatric recipients, 79% of
these kidneys were eventually transplanted and 6% (28) of
485 went to paediatric kidney-only recipients (Table 2).
Outcome in paediatric patients for whom a kidney
was offered and declined
One child died while waiting for a transplant out of the 204
children who had a kidney offer declined on their behalf dur-
ing the study. Eighty-four percent (171) of 204 children have
been transplanted and have a functioning graft (Fig. 3).
The waiting time for a child to be transplanted after an offer
was declined for them was 0 to 1701 (median 198) days
(Table 3 for all children who received a transplant and
Table 4 for those patients with initial kidney decline due to
donor reasons or inappropriate size). These data consider the
outcome following the patients first declined offer between
2009 and 2014. Many patients experienced more than one
offer decline during this period and/or experienced declined
offers outside of this time period. The data do not take account
of any transplants prior to the decline offer of interest.
Prospective study of reasons for decline of a kidney
for a paediatric recipient
There were 60 and 41 kidneys declined for paediatric recipi-
ents during the 2 years of prospective data collection (2011
and 2014, respectively). Although the absolute number of
declines fell, the decline rate actually rose slightly from 59%
in 2011 to 64% in 2014. This is because the number of chil-
dren active on the kidney transplant waiting list fell from 101
in 2011 to 64 in 2014. One hundred percent of the additional
supplemental data forms were returned from ten paediatric
renal transplant centres in the UK.
In 75% of kidney declines for paediatric recipients, donor
poor health or cause of death was cited as a reason for decline
(Table 5). In order of importance, the three main donor health
or cause of death reasons for decline were as follows: (1) death
due to suspected meningoencephalitis without an identified
Table 1 Outcome of 615 kidneys from 308 donors that were declined for paediatric recipients from 2009 to 2014 in the UK (46 paediatric kidney only
transplants were from 43 donors)
Outcome of organ after decline
for paediatric recipient
N 1-year patient survival 1-year renal allograft survival 3-year patient survival 3-year renal allograft survival
% Survival 95% CI % Survival 95% CI % Survival 95% CI % Survival 95% CI
Not transplanted 112
Paediatric kidney only 46 97.7 84.6 99.7 89.1 75.8 95.3 97.7 84.6 99.7 82 67.1 90.6
Adult kidney only 384 95.7 92.7 97.5 96 93.5 97.6 93.1 89.1 95.6 93.9 90.7 96.1
Adult kidney and pancreas 61 100 – – 96.7 87.5 99.2 97.9 85.8 99.7 87.4 73.5 94.3
Other 12a
Patient and renal allograft survival data to 24 July 2016. ‘Other’ category includes double kidney (paediatric and adult), kidney and liver (paediatric and
adult) and kidney and small bowel (adult). 4/12 kidneys went to children
N number, CI confidence interval
a Insufficient events in each group to be able to report survival
Table 2 Outcome of 485 kidneys from 243 donors that were declined due to donor reasons or size mismatch for paediatric recipients from 2009 to
2014 in the UK
Outcome of organ after decline
for paediatric recipient
N 1-year patient survival 1-year renal allograft survival 3-year patient survival 3-year renal allograft survival
% Survival 95% CI % Survival 95% CI % Survival 95% CI % Survival 95% CI
Not transplanted 102
Paediatric kidney only 28 96.3 76.5 99.5 82.1 62.3 92.1 96.3 76.5 99.5 78.6 58.4 89.8
Adult kidney only 308 95.1 91.5 97.2 95.7 92.7 97.5 92.2 87.9 95 93.7 90.1 96
Adult kidney and pancreas 40 100 – – 97.5 83.5 99.6 100 – – 85.9 69.2 93.9
Other 7a
Patient and renal allograft survival data to 24 July 2016. ‘Other’ category includes double kidney (paediatric and adult), kidney and liver (paediatric and
adult), and kidney and small bowel (adult). Two out of seven kidneys went to children
N number, CI confidence interval
a Insufficient events in each group to be able to report survival
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organism, (2) virology (hepatitis B or C) or concern over
donor substance misuse without virology results and (3) death
from brain tumour without a histological diagnosis. There was
no statistically significant difference between the 2 years in
any of the reasons for decline (chi-squared test).
Discussion
Our findings show that kidneys declined for a paediatric re-
cipient can have acceptable 1 and 3-year patient and renal
allograft survival if eventually transplanted. Short-term renal
allograft outcomes are better if these organs are transplanted
into adult rather than paediatric recipients. The results also
show that most children who have a kidney offer declined
on their behalf will eventually be transplanted, but the median
time to transplant is over 6 months. One child who initially
had a kidney declined on their behalf died whilst waiting for a
transplant. There are few studies in the literature reporting
outcomes after declined kidney offers, and ours is the first to
systematically assess organ declines for paediatric recipients
across a national organ allocation network.
Whilst the observational nature of this study does not
allow us to predict whether each child in this study would
have benefitted from receiving the organ initially declined
for them, the fact that 82% of 615 kidneys were eventually
transplanted suggests that some of these kidneys were ap-
propriate for paediatric transplantation, acknowledging dif-
ferent risk-benefit ratios in paediatric and adult renal trans-
plant recipients. A kidney that is appropriate for an adult
recipient is not necessarily appropriate for a paediatric re-
cipient. The finding that 3-year renal allograft survival in
the kidneys transplanted to adult recipients is acceptable
cannot necessarily be applied to paediatric recipients.
However, although most children with an initial decline
were eventually transplanted, this study has demonstrated
that declining a kidney offer for a child in the UK extends
the transplant waiting time by a further 6 months on aver-
age. Whilst a child waiting an additional 6 months on an
optimised form of renal replacement therapy (such as noc-
turnal home haemodialysis) may not suffer many additional
risks, a child on sub-optimal dialysis treatment with other
co-morbidities may suffer significant morbidity by waiting
an additional 6 months for a transplant. Recent evidence has
also shown that children not on dialysis at the time of trans-
plant have improved renal allograft survival compared to
those on dialysis at the time of transplant, although short
periods of dialysis (< 6 months duration) did not confer any
additional risk to renal allograft survival [8]. Therefore, the
decision to refuse a kidney offer for a child must not be
taken lightly, and better evidence is required to help clini-
cians make these difficult decisions.
As well as the observational nature of this study, a fur-
ther limitation to the conclusions we can draw from these
results is the small number of declined organs that eventu-
ally went to other paediatric recipients (46 in total). This has
resulted in 1 and 3-year renal allograft survival estimates
with wide confidence intervals and may in part account for
the finding that 1-year renal allograft survival is better in
adult recipients. A possible explanation for these results is
that children who eventually accept a kidney that was ini-
tially declined for a paediatric recipient may be children
who are difficult to transplant or have been waiting for a
Fig. 3 Patient outcomes for children who had a kidney offer declined on
their behalf in the UK from 2009 to 2014 (logarithmic scale) outcomes
taken after their first decline during this period (many patients had more
than one declined offer and may have had declines outside this time
period)
Table 3 Time between declined kidney offer of all children from 2009
to 2014 to transplantation
Donor type N Median time
to transplant (days)
Range (days)
DBD 129 198 0–1701
DCD 8 152 55–445
LD 41 206 6–1093
N number, DBD donation after brain death, DCD donation after cardiac
death, LD living donor
Table 4 Time between declined kidney offer due to donor reasons or
size mismatch from 2009 to 2014 to transplantation
Donor type N Median time
to transplant (days)
Range (days)
DBD 112 192 1–892
DCD 8 152 55–445
LD 37 186 6–1093
N number, DBD donation after brain death, DCD donation after cardiac
death, LD living donor
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long time; therefore, the children that eventually get the
kidney may have inferior renal allograft survival due to
their individual recipient characteristics.
Once the 3-year renal allograft survival data is consid-
ered, it appears that adult recipients can have better out-
comes than paediatric recipients when they get a kidney
that was initially declined for a paediatric recipient. We
cannot draw firm conclusions over the reasons for this,
but the renal allograft survival estimate in our study does
not differ significantly from renal allograft survival in larg-
er cohorts of paediatric donation after brain death (DBD)
kidney recipients. One-year renal allograft survival was
89% [95% CI 75.8–95.3%] for paediatric recipients, which
is comparable to data from the UK transplant registry for
955 DBD kidney transplants for children where 1-year al-
lograft survival was 93% [95% CI 91.6–94.8%; unpub-
lished data: NHS Blood and Transplant]. Three-year renal
allograft survival in the 46 kidneys that went to paediatric
recipients in our study was 82% [95% CI 67.1–90.6%],
which is also comparable to data from the UK transplant
registry where 3-year allograft survival was 87% [95% CI
84.8–89%; unpublished data: NHS Blood and Transplant].
The difference in survival between patients in our study and
the whole of the UK is not statistically significant, at both 1
and 3 years.
When we consider the 485 kidneys declined due to donor
reasons or inappropriate size for paediatric recipients, only 28
of these were eventually transplanted to other paediatric recip-
ients (Table 4). One-year renal allograft survival in this sub-
group is 82% [95% CI 62.3–92.1%]. Although this does not
differ significantly from the data for 955 DBD kidney trans-
plants above, this is partly because the confidence intervals are
wide due to small numbers. It is interesting to note that both 1
and 3-year renal allograft survival is worse for paediatric re-
cipients than adult recipients, although the number in this sub-
group is small and it is difficult to draw firm conclusions.
The prospective observational part of this study has en-
abled us to better understand the most common reasons for
decline of a kidney offer for a paediatric recipient. Across the
2 years studied, 75% of declines cited poor donor health or
cause of death as a reason for declining the organ. Nineteen
percent of declines cite an inappropriate size match between
donor and recipient as a reason for declining the organ.
The importance of good donor health is emphasised in the
literature [6, 9], and this is particularly the case for paediatric
recipients. Children with ESKD are likely to need multiple
Table 5 Baseline data and
reasons for decline for all kidneys
declined on behalf of paediatric
recipients in the UK from
prospective audit data in 2011 and
2014
2011 2014 Both Years
Total number of declines 60 41 101
Decline rate (based on total number on waiting list) 59% 64% 61%
Number of different donors 51 31 82
Number of different recipients 40 32 72
Donor age in years (median) 2–50 (38) 4–50 (40) 2–50 (40)
Recipient age in years (median) 1–17 (10) 2–17 (12) 1–17 (10)
Donor weight in kg (median) 14–180
(75)
16–137 (71) 14–180
(75)
Recipient weight in kg (median) 11–60 (20) 10–84 (32) 10–84 (26)
Donor height in cm (median) 91–200
(168)
117–189
(170)
91–200
(170)
Recipient height in cm (median) 76–178
(116)
71–171
(133)
71–178
(125)
Reasons for decline
Donor poor health or cause of death 72% 80% 75%
Size mismatch 22% 15% 19%
Awaiting a better offer or live transplant 5% 10% 7%
Poor HLA match or positive cross match 8% 2% 6%
Recipient unfit for surgery 3% 2% 3%
Lack of staff to perform organ retrieval or transplant 3% 2% 3%
Ischaemia time (CIT or WIT) too long or organ damage during
retrieval
3% 2% 3%
Other 3% 5% 4%
Some declined offers had multiple reasons for the decline; the percentages shown in the table reflect the propor-
tion of declines where that reason applied
HLA human leukocyte antigen, CIT cold ischaemia time,WITwarm ischaemia time
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kidney transplants across their life, so maximising the longev-
ity of the kidneys they receive during childhood is paramount
[10]. However, there is emerging evidence from adult litera-
ture that suggests that inferior but acceptable transplant out-
comes can be achieved with ‘marginal’ or ‘extended-criteria’
donors [6, 9]. Whilst this does not permit automatic extension
of this evidence to paediatric recipients, when the negative
impact of other forms of renal replacement therapy such as
dialysis is considered [11], it may be prudent to consider wid-
ening the criteria of potential organ acceptance for paediatric
recipients. We are already seeing increased utilisation of do-
nation after DCD kidney transplants in both adults and chil-
dren with good outcomes to date [12, 13], so there may be a
case for extending the criteria for organ acceptance for paedi-
atric recipients.
The issue of size mismatch is a controversial one in paedi-
atric renal transplantation. Whilst the potential surgical and
haemodynamic problems of large kidneys for small recipients
are well documented [7], there are reports of similar renal
allograft outcomes to size-matched grafts [14] and these con-
cerns must be balanced against the well-recognised risks of
staying on dialysis in such young patients [11]. This is even
more so the case in this situation, where a size mismatch is
also likely to occur for any potential living-related donor, and
may also prevent this type of transplantation occurring. Size
mismatch is not listed as a contraindication in the NHS Blood
and Transplant guideline (2013) outlining reasons for decline
of kidneys for paediatric recipients [15]. This is generally a
decision made at a local level by the recipient’s individual
nephrologist and transplant surgeon, where size mismatch
may eventually be a factor which results in a decision to de-
cline by the operating surgeon.
Although this part of our study helps us to understand the
commonest reasons for decline of a kidney offer for a pae-
diatric recipient, further study is required to help clarify
these factors and to provide evidence for guideline devel-
opment. In particular, detailed analysis of which donor
health issues preclude transplant and the specifics of size
mismatch (e.g. kidney too big or small) will help to evaluate
these factors further.
In conclusion, this study demonstrates that most kidneys
initially declined for paediatric transplantation can be success-
fully transplanted into both adult and paediatric recipients,
with acceptable 1 and 3-year patient and renal allograft sur-
vival (although there may be an advantage for adult renal
transplant recipients).
The decision to decline a kidney for a paediatric recip-
ient must not be taken lightly, as our results demonstrate
that children will wait an additional 6 months on average,
to receive a transplant. Robust evidence-based guidelines
are required to aid clinical decision making in order to
ensure that the most appropriate kidneys are selected for
paediatric recipients.
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